2013 ASH Annual Meeting and Exposition- KEY ABSTRACTS for Myeloproliferative Neoplasms December 7-10, 2013 – Ernest N. Morial Convention Center, New Orleans, LA Myeloproliferative Neoplasms Absracts Frequent Mutations in the Calreticulin Gene CALR in Myeloproliferative Neoplasms The Genomic Landscape of Myeloproliferative Neoplasms: Somatic Calr Mutations in the Majority of JAK2-Wildtype Patients Increased Platelet Thrombus Formation Under Flow […]
Medical scientists in Melbourne invent novel approach worldwide to Cure Leukemia
Combo Blood Cancer Treatment Attacking JAK2 Protein – A Possible Approach to Curing Leukemia Australian medical scientists have discovered a new approach which is regarded as the landmark to kill blood cancer cells for treating a large number of aggressive adult and childhood leukemia, Melbourne’s Peter MacCallum Cancer Centre said via the Friday’s media release. The report […]
Living Well with Myeloproliferative Neoplasms
MPN town meeting Andrew Schorr from Patient Power -November, 23, 2013 – MD Anderson Cancer Center – Houston, TX Growing research is leading to a new understanding of Myeloproliferative Neoplasms (MPNs), including Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF). Excitement is building among experts about new treatment options which are shaping up […]
Cancer Research & Treatment MPN Symposium 2013 Videos
7th International Patient Symposium on Myeloproliferative Neoplasms Click on the picture below for the VIDEOS from CR&T International Patient Symposium: Index of Topics Covered and Presenters: New Concepts in Basic Biology of MPNs – John Crispino, PHD What is the Value of Epigenetic Therapy in MPN Treatment? – Ronald […]
The Landscape of Treatment Options for Myeloproliferative Neoplasms is Changing
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 41
- Next Page »
